Skip to content
healthcare.dev

ORPHENADRINE CITRATE

NDC 43063-407, ORPHENADRINE CITRATE, tablet, extended release, from PD-Rx Pharmaceuticals, Inc..

Product NDC
43063-407
Status
Listed
Labeler
PD-Rx Pharmaceuticals, Inc.
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA040284
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/43063-407 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ORPHENADRINE CITRATE100 mg/1

Pharmacologic classes

Centrally-mediated Muscle Relaxation [PE]; Muscle Relaxant [EPC]

Package NDCNDC-11Package
43063-407-144306304071414 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (43063-407-14)
43063-407-204306304072020 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (43063-407-20)
43063-407-304306304073030 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (43063-407-30)
43063-407-604306304076060 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (43063-407-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/87d78229-f022-4b42-a03c-4e6a985c714f

Use it

Look up 43063-407 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/43063-407 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 43063-407. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.